Evaluation of Cardiovascular Outcomes in Patients Undergoing Orthotopic Liver Transplantation: a Retrospective Cohort Study
Overview
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 100
- Locations
- 2
- Primary Endpoint
- Cardiovascular death
Overview
Brief Summary
All patients with orthotopic liver transplantation who are evaluated and followed at each participating centers will be recorded in this study. Within this register a characterization of patients and therapy will be done. Prognostic factors of defined clinical relevant endpoints will be evaluated.
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All patients with ortothopic liver transplantation and at least 2 year follow-up at the referral center
Exclusion Criteria
- •Missing Informed Consent Form
- •Missing Contact Informations for Follow up
Outcomes
Primary Outcomes
Cardiovascular death
Time Frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months
death due to cardiac causes (myocardial infraction and/or stroke)
cardiovascular complication
Time Frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 120 months
fatal and non fatal myocardial infraction and/or stroke
Secondary Outcomes
No secondary outcomes reported
Investigators
Alfredo Caturano
Principal Investigator
University of Campania "Luigi Vanvitelli"